What if we could prevent psychiatric diseases, cure Alzheimer’s, or find a way to effectively treat autoimmune diseases? When it comes to finding the answers to your complex disease questions, look no further than Applied Biosystems. We bring together the flexibility, focus, and breadth of solutions you need to identify, understand, and treat infectious diseases with confidence.
Complex disease research spotlight
Dr. Iain Gallagher, lecturer in the faculty of Health Sciences and Sport at the University of Stirling, is interested in the effects of metabolic disease on muscle function. In a recent research study, he set out to define the transcriptomic landscape in type 2 diabetes.
miRNA exists as extremely short segments—around 22 nucleotides—of RNA. These segments were previously dismissed as non-coding and therefore functionless, but studies have shown that these tiny genomic parcels are crucial regulators for gene transcription
As head of the RNA-Mediated Mechanisms of Disease group at the University of Exeter Medical School, Dr. Lorna Harries leads the group’s investigation into how and why we age, and the reason age is a major risk factor in diseases like type 2 diabetes.
Webinar: Polygenic Risk Score analysis for Alzheimer's disease risk
The utility of Polygenic Risk Scores (PRS) is gaining researchers' attention for identifying individual genetic risk and disease risk prediction in Alzheimer's Disease (AD) at both the early and pre symptomatic stages of the disease. This can help in patient stratification for clinical trial research to develop targeted treatments for AD.
Applied Biosystems resources for complex disease research
Applied Biosystems technologies
For Research Use Only. Not for use in diagnostic procedures.
